Title | Shifting the focus of zebrafish toward a model of the tumor microenvironment. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Weiss JM, Lumaquin-Yin D, Montal E, Suresh S, Leonhardt CS, White RM |
Journal | Elife |
Volume | 11 |
Date Published | 2022 Dec 20 |
ISSN | 2050-084X |
Keywords | Animals, Ecosystem, Models, Biological, Neoplasms, Tumor Microenvironment, Zebrafish |
Abstract | Cancer cells exist in a complex ecosystem with numerous other cell types in the tumor microenvironment (TME). The composition of this tumor/TME ecosystem will vary at each anatomic site and affects phenotypes such as initiation, metastasis, and drug resistance. A mechanistic understanding of the large number of cell-cell interactions between tumor and TME requires models that allow us to both characterize as well as genetically perturb this complexity. Zebrafish are a model system optimized for this problem, because of the large number of existing cell-type-specific drivers that can label nearly any cell in the TME. These include stromal cells, immune cells, and tissue resident normal cells. These cell-type-specific promoters/enhancers can be used to drive fluorophores to facilitate imaging and also CRISPR cassettes to facilitate perturbations. A major advantage of the zebrafish is the ease by which large numbers of TME cell types can be studied at once, within the same animal. While these features make the zebrafish well suited to investigate the TME, the model has important limitations, which we also discuss. In this review, we describe the existing toolset for studying the TME using zebrafish models of cancer and highlight unique biological insights that can be gained by leveraging this powerful resource. |
DOI | 10.7554/eLife.69703 |
Alternate Journal | Elife |
PubMed ID | 36538362 |
PubMed Central ID | PMC9767465 |
Grant List | R01 CA238317 / CA / NCI NIH HHS / United States R01 CA229215 / CA / NCI NIH HHS / United States DP2 CA186572 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States |
Submitted by bel2021 on January 19, 2023 - 2:05pm